Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 202

1.

Increasing autism acceptance: The impact of the Sesame Street "See Amazing in All Children" initiative.

Anthony BJ, Robertson HA, Verbalis A, Myrick Y, Troxel M, Seese S, Anthony LG.

Autism. 2019 May 22:1362361319847927. doi: 10.1177/1362361319847927. [Epub ahead of print]

PMID:
31113212
2.

Feasibility and preliminary efficacy of a parent-mediated sexual education curriculum for youth with autism spectrum disorders.

Pugliese CE, Ratto AB, Granader Y, Dudley KM, Bowen A, Baker C, Anthony LG.

Autism. 2019 May 17:1362361319842978. doi: 10.1177/1362361319842978. [Epub ahead of print]

PMID:
31096780
3.

Can an amino acid-based oral rehydration solution be effective in managing immune therapy-induced diarrhea?

Hendrie JD, Chauhan A, Nelson NR, Anthony LB.

Med Hypotheses. 2019 Jun;127:66-70. doi: 10.1016/j.mehy.2019.03.023. Epub 2019 Mar 27.

PMID:
31088651
4.

Two cases of neuroangiostrongyliasis: A rare disease because rarely considered or rarely diagnosed?

Berkhout A, Prociv P, Anthony H, Anthony LT, Clare N.

J Paediatr Child Health. 2019 Apr 3. doi: 10.1111/jpc.14461. [Epub ahead of print]

PMID:
30945367
5.

Quantitative assessment of carotid plaque morphology (geometry and tissue composition) using computed tomography angiography.

Chrencik MT, Khan AA, Luther L, Anthony L, Yokemick J, Patel J, Sorkin JD, Sikdar S, Lal BK.

J Vasc Surg. 2019 Mar 5. pii: S0741-5214(19)30141-7. doi: 10.1016/j.jvs.2018.11.050. [Epub ahead of print]

PMID:
30850296
6.

Multiple sclerosis outcomes after cancer immunotherapy.

Garcia CR, Jayswal R, Adams V, Anthony LB, Villano JL.

Clin Transl Oncol. 2019 Feb 20. doi: 10.1007/s12094-019-02060-8. [Epub ahead of print]

PMID:
30788836
7.

Integrating a 92-Gene Expression Analysis for the Management of Neuroendocrine Tumors of Unknown Primary

Chauhan A, Farooqui Z, Silva SR, Murray A, Hodges KB, Yu Q, Myint ZW, Raajesekar AK, Weiss H, Arnold S, Evers BM, Anthony L.

Asian Pac J Cancer Prev. 2019 Jan 25;20(1):113-116.

8.

Long-Term Safety Experience with Telotristat Ethyl Across Five Clinical Studies in Patients with Carcinoid Syndrome.

Anthony LB, Kulke MH, Caplin ME, Bergsland E, Öberg K, Pavel M, Hörsch D, Warner RRP, O'Dorisio TM, Dillon JS, Lapuerta P, Kassler-Taub K, Jiang W.

Oncologist. 2019 Jan 16. pii: theoncologist.2018-0236. doi: 10.1634/theoncologist.2018-0236. [Epub ahead of print]

PMID:
30651397
9.

Can a High-grade Neuroendocrine Carcinoma be Functional?

Graham C, Chauhan A, Anthony L.

Am J Med Sci. 2019 Mar;357(3):258-262. doi: 10.1016/j.amjms.2018.11.001. Epub 2018 Nov 10. Review.

PMID:
30638597
10.

Immune Checkpoint Inhibitors in Pediatric Solid Tumors: Status in 2018.

Kabir TF, Chauhan A, Anthony L, Hildebrandt GC.

Ochsner J. 2018 Winter;18(4):370-376. doi: 10.31486/toj.18.0055. Review.

11.

Search for CP Violation in Neutrino and Antineutrino Oscillations by the T2K Experiment with 2.2×10^{21} Protons on Target.

Abe K, Akutsu R, Ali A, Amey J, Andreopoulos C, Anthony L, Antonova M, Aoki S, Ariga A, Ashida Y, Azuma Y, Ban S, Barbi M, Barker GJ, Barr G, Barry C, Batkiewicz M, Bench F, Berardi V, Berkman S, Berner RM, Berns L, Bhadra S, Bienstock S, Blondel A, Bolognesi S, Bourguille B, Boyd SB, Brailsford D, Bravar A, Bronner C, Buizza Avanzini M, Calcutt J, Campbell T, Cao S, Cartwright SL, Catanesi MG, Cervera A, Chappell A, Checchia C, Cherdack D, Chikuma N, Christodoulou G, Coleman J, Collazuol G, Coplowe D, Cudd A, Dabrowska A, De Rosa G, Dealtry T, Denner PF, Dennis SR, Densham C, Di Lodovico F, Dokania N, Dolan S, Drapier O, Duffy KE, Dumarchez J, Dunne P, Emery-Schrenk S, Ereditato A, Fernandez P, Feusels T, Finch AJ, Fiorentini GA, Fiorillo G, Francois C, Friend M, Fujii Y, Fujita R, Fukuda D, Fukuda Y, Gameil K, Giganti C, Gizzarelli F, Golan T, Gonin M, Hadley DR, Haegel L, Haigh JT, Hamacher-Baumann P, Hansen D, Harada J, Hartz M, Hasegawa T, Hastings NC, Hayashino T, Hayato Y, Hiramoto A, Hogan M, Holeczek J, Hosomi F, Ichikawa AK, Ikeda M, Imber J, Inoue T, Intonti RA, Ishida T, Ishii T, Ishitsuka M, Iwamoto K, Izmaylov A, Jamieson B, Jiang M, Johnson S, Jonsson P, Jung CK, Kabirnezhad M, Kaboth AC, Kajita T, Kakuno H, Kameda J, Karlen D, Katori T, Kato Y, Kearns E, Khabibullin M, Khotjantsev A, Kim H, Kim J, King S, Kisiel J, Knight A, Knox A, Kobayashi T, Koch L, Koga T, Koller PP, Konaka A, Kormos LL, Koshio Y, Kowalik K, Kubo H, Kudenko Y, Kurjata R, Kutter T, Kuze M, Labarga L, Lagoda J, Lamoureux M, Lasorak P, Laveder M, Lawe M, Licciardi M, Lindner T, Liptak ZJ, Litchfield RP, Li X, Longhin A, Lopez JP, Lou T, Ludovici L, Lu X, Magaletti L, Mahn K, Malek M, Manly S, Maret L, Marino AD, Martin JF, Martins P, Maruyama T, Matsubara T, Matveev V, Mavrokoridis K, Ma WY, Mazzucato E, McCarthy M, McCauley N, McFarland KS, McGrew C, Mefodiev A, Metelko C, Mezzetto M, Minamino A, Mineev O, Mine S, Missert A, Miura M, Moriyama S, Morrison J, Mueller TA, Murphy S, Nagai Y, Nakadaira T, Nakahata M, Nakajima Y, Nakamura KG, Nakamura K, Nakamura KD, Nakanishi Y, Nakayama S, Nakaya T, Nakayoshi K, Nantais C, Nielsen C, Niewczas K, Nishikawa K, Nishimura Y, Nonnenmacher TS, Novella P, Nowak J, O'Keeffe HM, O'Sullivan L, Okumura K, Okusawa T, Oryszczak W, Oser SM, Owen RA, Oyama Y, Palladino V, Palomino JL, Paolone V, Paudyal P, Pavin M, Payne D, Pickering L, Pidcott C, Pinzon Guerra ES, Pistillo C, Popov B, Porwit K, Posiadala-Zezula M, Pritchard A, Quilain B, Radermacher T, Radicioni E, Ratoff PN, Reinherz-Aronis E, Riccio C, Rondio E, Rossi B, Roth S, Rubbia A, Ruggeri AC, Rychter A, Sakashita K, Sánchez F, Sasaki S, Scantamburlo E, Scholberg K, Schwehr J, Scott M, Seiya Y, Sekiguchi T, Sekiya H, Sgalaberna D, Shah R, Shaikhiev A, Shaker F, Shaw D, Shiozawa M, Smirnov A, Smy M, Sobczyk JT, Sobel H, Sonoda Y, Steinmann J, Stewart T, Stowell P, Suda Y, Suvorov S, Suzuki A, Suzuki SY, Suzuki Y, Sztuc AA, Tacik R, Tada M, Takeda A, Takeuchi Y, Tamura R, Tanaka HK, Tanaka HA, Thakore T, Thompson LF, Toki W, Touramanis C, Tsui KM, Tsukamoto T, Tzanov M, Uchida Y, Uno W, Vagins M, Vallari Z, Vasseur G, Vilela C, Vladisavljevic T, Volkov VV, Wachala T, Walker J, Wang Y, Wark D, Wascko MO, Weber A, Wendell R, Wilking MJ, Wilkinson C, Wilson JR, Wilson RJ, Wret C, Yamada Y, Yamamoto K, Yamasu S, Yanagisawa C, Yang G, Yano T, Yasutome K, Yen S, Yershov N, Yokoyama M, Yoshida T, Yu M, Zalewska A, Zalipska J, Zaremba K, Zarnecki G, Ziembicki M, Zimmerman ED, Zito M, Zsoldos S, Zykova A; T2K Collaboration.

Phys Rev Lett. 2018 Oct 26;121(17):171802. doi: 10.1103/PhysRevLett.121.171802.

PMID:
30411920
12.

Revisiting the Link: Evidence of the Rates of Autism in Studies of Gender Diverse Individuals.

Strang JF, Janssen A, Tishelman A, Leibowitz SF, Kenworthy L, McGuire JK, Edwards-Leeper L, Mazefsky CA, Rofey D, Bascom J, Caplan R, Gomez-Lobo V, Berg D, Zaks Z, Wallace GL, Wimms H, Pine-Twaddell E, Shumer D, Register-Brown K, Sadikova E, Anthony LG.

J Am Acad Child Adolesc Psychiatry. 2018 Nov;57(11):885-887. doi: 10.1016/j.jaac.2018.04.023.

PMID:
30392631
13.

Medial and Lateral Patellofemoral Joint Retinaculum Thickness in People With Patellofemoral Pain: A Case-Control Study.

Lack S, Anthony L, Noake J, Brennan K, Zhang B, Morrissey D.

J Ultrasound Med. 2019 Jun;38(6):1483-1490. doi: 10.1002/jum.14828. Epub 2018 Sep 24.

PMID:
30251436
14.

Management of Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia: Review and a Single Center Experience.

Myint ZW, McCormick J, Chauhan A, Behrens E, Anthony LB.

Lung. 2018 Oct;196(5):577-581. doi: 10.1007/s00408-018-0149-z. Epub 2018 Aug 25. Review.

PMID:
30167840
15.

"They Thought It Was an Obsession": Trajectories and Perspectives of Autistic Transgender and Gender-Diverse Adolescents.

Strang JF, Powers MD, Knauss M, Sibarium E, Leibowitz SF, Kenworthy L, Sadikova E, Wyss S, Willing L, Caplan R, Pervez N, Nowak J, Gohari D, Gomez-Lobo V, Call D, Anthony LG.

J Autism Dev Disord. 2018 Dec;48(12):4039-4055. doi: 10.1007/s10803-018-3723-6.

PMID:
30140984
16.

Neoadjuvant Nab-paclitaxel and Gemcitabine in Borderline Resectable or Locally Advanced Unresectable Pancreatic Adenocarcinoma in Patients Who Are Ineligible for FOLFIRINOX.

Peterson SL, Husnain M, Pollack T, Pimentel A, Loaiza-Bonilla A, Westendorf-Overley C, Ratermann K, Anthony L, Desimone P, Goel G, Kudrimoti M, Dineen S, Tzeng CD, Hosein PJ.

Anticancer Res. 2018 Jul;38(7):4035-4039. doi: 10.21873/anticanres.12692.

PMID:
29970528
17.

Search for Boosted Dark Matter Interacting with Electrons in Super-Kamiokande.

Kachulis C, Abe K, Bronner C, Hayato Y, Ikeda M, Iyogi K, Kameda J, Kato Y, Kishimoto Y, Marti L, Miura M, Moriyama S, Nakahata M, Nakano Y, Nakayama S, Okajima Y, Orii A, Pronost G, Sekiya H, Shiozawa M, Sonoda Y, Takeda A, Takenaka A, Tanaka H, Tasaka S, Tomura T, Akutsu R, Kajita T, Kaneyuki K, Nishimura Y, Okumura K, Tsui KM, Labarga L, Fernandez P, Blaszczyk FDM, Gustafson J, Kearns E, Raaf JL, Stone JL, Sulak LR, Berkman S, Tobayama S, Goldhaber M, Elnimr M, Kropp WR, Mine S, Locke S, Weatherly P, Smy MB, Sobel HW, Takhistov V, Ganezer KS, Hill J, Kim JY, Lim IT, Park RG, Himmel A, Li Z, O'Sullivan E, Scholberg K, Walter CW, Ishizuka T, Nakamura T, Jang JS, Choi K, Learned JG, Matsuno S, Smith SN, Amey J, Litchfield RP, Ma WY, Uchida Y, Wascko MO, Cao S, Friend M, Hasegawa T, Ishida T, Ishii T, Kobayashi T, Nakadaira T, Nakamura K, Oyama Y, Sakashita K, Sekiguchi T, Tsukamoto T, Abe KE, Hasegawa M, Suzuki AT, Takeuchi Y, Yano T, Hayashino T, Hiraki T, Hirota S, Huang K, Jiang M, Nakamura KE, Nakaya T, Quilain B, Patel ND, Wendell RA, Anthony LHV, McCauley N, Pritchard A, Fukuda Y, Itow Y, Murase M, Muto F, Mijakowski P, Frankiewicz K, Jung CK, Li X, Palomino JL, Santucci G, Vilela C, Wilking MJ, Yanagisawa C, Ito S, Fukuda D, Ishino H, Kibayashi A, Koshio Y, Nagata H, Sakuda M, Xu C, Kuno Y, Wark D, Di Lodovico F, Richards B, Tacik R, Kim SB, Cole A, Thompson L, Okazawa H, Choi Y, Ito K, Nishijima K, Koshiba M, Totsuka Y, Suda Y, Yokoyama M, Calland RG, Hartz M, Martens K, Simpson C, Suzuki Y, Vagins MR, Hamabe D, Kuze M, Yoshida T, Ishitsuka M, Martin JF, Nantais CM, Tanaka HA, Konaka A, Chen S, Wan L, Zhang Y, Wilkes RJ, Minamino A; Super-Kamiokande Collaboration.

Phys Rev Lett. 2018 Jun 1;120(22):221301. doi: 10.1103/PhysRevLett.120.221301.

18.

PSA-selective activation of cytotoxic human serine proteases within the tumor microenvironment as a therapeutic strategy to target prostate cancer.

Rogers OC, Anthony L, Rosen DM, Brennen WN, Denmeade SR.

Oncotarget. 2018 Apr 27;9(32):22436-22450. doi: 10.18632/oncotarget.25091. eCollection 2018 Apr 27.

19.

Capecitabine and Temozolomide in Neuroendocrine Tumor of Unknown Primary.

Chauhan A, Farooqui Z, Murray LA, Weiss HL, War Myint Z, Raajasekar AKA, Evers BM, Arnold S, Anthony L.

J Oncol. 2018 May 7;2018:3519247. doi: 10.1155/2018/3519247. eCollection 2018.

20.

Changes in Weight Associated With Telotristat Ethyl in the Treatment of Carcinoid Syndrome.

Weickert MO, Kaltsas G, Hörsch D, Lapuerta P, Pavel M, Valle JW, Caplin ME, Bergsland E, Kunz PL, Anthony LB, Grande E, Öberg K, Welin S, Lombard-Bohas C, Ramage JK, Kittur A, Yang QM, Kulke MH.

Clin Ther. 2018 Jun;40(6):952-962.e2. doi: 10.1016/j.clinthera.2018.04.006. Epub 2018 May 1.

21.

Global burden of neuroendocrine tumors and changing incidence in Kentucky.

Chauhan A, Yu Q, Ray N, Farooqui Z, Huang B, Durbin EB, Tucker T, Evers M, Arnold S, Anthony LB.

Oncotarget. 2018 Apr 10;9(27):19245-19254. doi: 10.18632/oncotarget.24983. eCollection 2018 Apr 10.

22.

Correction: Worldwide increased prevalence of human adenovirus type 3 (HAdV-3) respiratory infections is well correlated with heterogeneous hypervariable regions (HVRs) of hexon.

Haque E, Banik U, Monowar T, Anthony L, Adhikary AK.

PLoS One. 2018 Apr 18;13(4):e0196263. doi: 10.1371/journal.pone.0196263. eCollection 2018.

23.

PSA-alpha-2-macroglobulin complex is enzymatically active in the serum of patients with advanced prostate cancer and can degrade circulating peptide hormones.

Kostova MB, Brennen WN, Lopez D, Anthony L, Wang H, Platz E, Denmeade SR.

Prostate. 2018 Aug;78(11):819-829. doi: 10.1002/pros.23539. Epub 2018 Apr 16.

PMID:
29659051
24.

Worldwide increased prevalence of human adenovirus type 3 (HAdV-3) respiratory infections is well correlated with heterogeneous hypervariable regions (HVRs) of hexon.

Haque E, Banik U, Monowar T, Anthony L, Adhikary AK.

PLoS One. 2018 Mar 28;13(3):e0194516. doi: 10.1371/journal.pone.0194516. eCollection 2018. Erratum in: PLoS One. 2018 Apr 18;13(4):e0196263.

25.

Immune checkpoint inhibitors in large cell neuroendocrine carcinoma: current status.

Chauhan A, Arnold SM, Kolesar J, Thomas HE, Evers M, Anthony L.

Oncotarget. 2018 Feb 22;9(18):14738-14740. doi: 10.18632/oncotarget.24553. eCollection 2018 Mar 6.

26.

Immune checkpoint inhibitors in neuroendocrine tumors: A single institution experience with review of literature.

Chauhan A, Horn M, Magee G, Hodges K, Evers M, Arnold S, Anthony L.

Oncotarget. 2017 Dec 28;9(10):8801-8809. doi: 10.18632/oncotarget.23753. eCollection 2018 Feb 6.

27.

Telotristat ethyl in carcinoid syndrome: safety and efficacy in the TELECAST phase 3 trial.

Pavel M, Gross DJ, Benavent M, Perros P, Srirajaskanthan R, Warner RRP, Kulke MH, Anthony LB, Kunz PL, Hörsch D, Weickert MO, Lapuerta P, Jiang W, Kassler-Taub K, Wason S, Fleming R, Fleming D, Garcia-Carbonero R.

Endocr Relat Cancer. 2018 Mar;25(3):309-322. doi: 10.1530/ERC-17-0455. Epub 2018 Jan 12.

28.

Prognostic Factors in Typical and Atypical Pulmonary Carcinoids.

Ramirez RA, Beyer DT, Diebold AE, Voros BA, Chester MM, Wang YZ, Boudreaux JP, Woltering EA, Uhlhorn AP, Ryan P, Campeau RJ, Anthony LB.

Ochsner J. 2017 Winter;17(4):335-340.

29.

What About the Girls? Sex-Based Differences in Autistic Traits and Adaptive Skills.

Ratto AB, Kenworthy L, Yerys BE, Bascom J, Wieckowski AT, White SW, Wallace GL, Pugliese C, Schultz RT, Ollendick TH, Scarpa A, Seese S, Register-Brown K, Martin A, Anthony LG.

J Autism Dev Disord. 2018 May;48(5):1698-1711. doi: 10.1007/s10803-017-3413-9.

30.

Understanding the Patient Experience with Carcinoid Syndrome: Exit Interviews from a Randomized, Placebo-controlled Study of Telotristat Ethyl.

Anthony L, Ervin C, Lapuerta P, Kulke MH, Kunz P, Bergsland E, Hörsch D, Metz DC, Pasieka J, Pavlakis N, Pavel M, Caplin M, Öberg K, Ramage J, Evans E, Yang QM, Jackson S, Arnold K, Law L, DiBenedetti DB.

Clin Ther. 2017 Nov;39(11):2158-2168. doi: 10.1016/j.clinthera.2017.09.013. Epub 2017 Oct 23.

31.

Transgender Youth Fertility Attitudes Questionnaire: Measure Development in Nonautistic and Autistic Transgender Youth and Their Parents.

Strang JF, Jarin J, Call D, Clark B, Wallace GL, Anthony LG, Kenworthy L, Gomez-Lobo V.

J Adolesc Health. 2018 Feb;62(2):128-135. doi: 10.1016/j.jadohealth.2017.07.022. Epub 2017 Oct 20.

PMID:
29033160
32.

Review of reviews on exposures to synthetic organic chemicals and children's neurodevelopment: Methodological and interpretation challenges.

LaKind JS, Anthony LG, Goodman M.

J Toxicol Environ Health B Crit Rev. 2017;20(8):390-422. doi: 10.1080/10937404.2017.1370847. Epub 2017 Sep 27. Review.

PMID:
28952888
33.

mTOR Kinase Inhibition Effectively Decreases Progression of a Subset of Neuroendocrine Tumors that Progress on Rapalog Therapy and Delays Cardiac Impairment.

Orr-Asman MA, Chu Z, Jiang M, Worley M, LaSance K, Koch SE, Carreira VS, Dahche HM, Plas DR, Komurov K, Qi X, Mercer CA, Anthony LB, Rubinstein J, Thomas HE.

Mol Cancer Ther. 2017 Nov;16(11):2432-2441. doi: 10.1158/1535-7163.MCT-17-0058. Epub 2017 Sep 1.

34.

Comprehensive genomic profiling in routine clinical practice leads to a low rate of benefit from genotype-directed therapy.

Hilal T, Nakazawa M, Hodskins J, Villano JL, Mathew A, Goel G, Wagner L, Arnold SM, DeSimone P, Anthony LB, Hosein PJ.

BMC Cancer. 2017 Aug 30;17(1):602. doi: 10.1186/s12885-017-3587-8.

35.

The BUFFET Program: Development of a Cognitive Behavioral Treatment for Selective Eating in Youth with Autism Spectrum Disorder.

Kuschner ES, Morton HE, Maddox BB, de Marchena A, Anthony LG, Reaven J.

Clin Child Fam Psychol Rev. 2017 Dec;20(4):403-421. doi: 10.1007/s10567-017-0236-3.

PMID:
28534237
36.

The Flexibility Scale: Development and Preliminary Validation of a Cognitive Flexibility Measure in Children with Autism Spectrum Disorders.

Strang JF, Anthony LG, Yerys BE, Hardy KK, Wallace GL, Armour AC, Dudley K, Kenworthy L.

J Autism Dev Disord. 2017 Aug;47(8):2502-2518. doi: 10.1007/s10803-017-3152-y.

PMID:
28527097
37.

Score of Toxic Epidermal Necrosis Predicts the Outcomes of Pediatric Epidermal Necrolysis.

Sorrell J, Anthony L, Rademaker A, Belknap SM, Callahan S, West DP, Paller AS.

Pediatr Dermatol. 2017 Jul;34(4):433-437. doi: 10.1111/pde.13172. Epub 2017 May 16.

PMID:
28508417
38.

Immune oncology and neuroendocrine tumors.

Chauhan A, Anthony L.

Ann Oncol. 2017 Sep 1;28(9):2322-2323. doi: 10.1093/annonc/mdx260. No abstract available.

PMID:
28505259
39.

Immune checkpoint-associated cardiotoxicity: case report with systematic review of literature.

Chauhan A, Burkeen G, Houranieh J, Arnold S, Anthony L.

Ann Oncol. 2017 Aug 1;28(8):2034-2038. doi: 10.1093/annonc/mdx213. Review. No abstract available.

PMID:
28472223
40.

Telotristat Ethyl, a Tryptophan Hydroxylase Inhibitor for the Treatment of Carcinoid Syndrome.

Kulke MH, Hörsch D, Caplin ME, Anthony LB, Bergsland E, Öberg K, Welin S, Warner RR, Lombard-Bohas C, Kunz PL, Grande E, Valle JW, Fleming D, Lapuerta P, Banks P, Jackson S, Zambrowicz B, Sands AT, Pavel M.

J Clin Oncol. 2017 Jan;35(1):14-23. Epub 2016 Oct 28.

PMID:
27918724
41.

Divergence of Age-Related Differences in Social-Communication: Improvements for Typically Developing Youth but Declines for Youth with Autism Spectrum Disorder.

Wallace GL, Dudley K, Anthony L, Pugliese CE, Orionzi B, Clasen L, Lee NR, Giedd JN, Martin A, Raznahan A, Kenworthy L.

J Autism Dev Disord. 2017 Feb;47(2):472-479. doi: 10.1007/s10803-016-2972-5.

PMID:
27878739
42.

Activity Limitation in Glaucoma: Objective Assessment by the Cambridge Glaucoma Visual Function Test.

Skalicky SE, McAlinden C, Khatib T, Anthony LM, Sim SY, Martin KR, Goldberg I, McCluskey P.

Invest Ophthalmol Vis Sci. 2016 Nov 1;57(14):6158-6166. doi: 10.1167/iovs.16-19458.

PMID:
27835712
43.

Initial Clinical Guidelines for Co-Occurring Autism Spectrum Disorder and Gender Dysphoria or Incongruence in Adolescents.

Strang JF, Meagher H, Kenworthy L, de Vries ALC, Menvielle E, Leibowitz S, Janssen A, Cohen-Kettenis P, Shumer DE, Edwards-Leeper L, Pleak RR, Spack N, Karasic DH, Schreier H, Balleur A, Tishelman A, Ehrensaft D, Rodnan L, Kuschner ES, Mandel F, Caretto A, Lewis HC, Anthony LG.

J Clin Child Adolesc Psychol. 2018 Jan-Feb;47(1):105-115. doi: 10.1080/15374416.2016.1228462. Epub 2016 Oct 24.

PMID:
27775428
44.

Lessons learned: Engaging culturally diverse families in neurodevelopmental disorders intervention research.

Ratto AB, Anthony BJ, Pugliese C, Mendez R, Safer-Lichtenstein J, Dudley KM, Kahn NF, Kenworthy L, Biel M, Martucci JL, Anthony LG.

Autism. 2017 Jul;21(5):622-634. doi: 10.1177/1362361316650394. Epub 2016 Jun 15.

45.

Defining the optimal timing of adjuvant therapy for resected pancreatic adenocarcinoma: A statewide cancer registry analysis.

Saeed H, Hnoosh D, Huang B, Durbin EB, McGrath PC, Desimone P, Maynard E, Anthony LB, Dineen SP, Hosein PJ, Tzeng CW.

J Surg Oncol. 2016 Sep;114(4):451-5. doi: 10.1002/jso.24314. Epub 2016 May 30.

PMID:
27238300
46.

IN VITRO CHEMOTHERAPY PROFILING OF WELL-DIFFERENTIATED MIDGUT NEUROENDOCRINE TUMORS (NETS) BASED ON INDIVIDUAL PATIENT TUMOR BIOMARKERS ANALYSIS.

Chauhan A, Wang YZ, Hall MA, Boudreaux JP, Woltering E, Anthony L.

J La State Med Soc. 2015 May-Jun;167(3):149. Epub 2015 Jun 15.

PMID:
27159467
47.

Primary Metastatic Small Intestinal Carcinoid Tumor Without Carcinoid Syndrome.

Anthony LB.

Oncology (Williston Park). 2015 Oct;29(10):755-6, 759. No abstract available.

48.

Are Non-intellectually Disabled Black Youth with ASD Less Impaired on Parent Report than Their White Peers?

Ratto AB, Anthony BJ, Kenworthy L, Armour AC, Dudley K, Anthony LG.

J Autism Dev Disord. 2016 Mar;46(3):773-81. doi: 10.1007/s10803-015-2614-3.

49.

Replication and Comparison of the Newly Proposed ADOS-2, Module 4 Algorithm in ASD Without ID: A Multi-site Study.

Pugliese CE, Kenworthy L, Bal VH, Wallace GL, Yerys BE, Maddox BB, White SW, Popal H, Armour AC, Miller J, Herrington JD, Schultz RT, Martin A, Anthony LG.

J Autism Dev Disord. 2015 Dec;45(12):3919-31. doi: 10.1007/s10803-015-2586-3.

50.

Unexpected Cardiac Masses.

Hilal T, Anthony LB, Sorrell VL.

JAMA Oncol. 2015 Dec;1(9):1343-4. doi: 10.1001/jamaoncol.2015.3077. No abstract available.

PMID:
26356843

Supplemental Content

Loading ...
Support Center